Vimarsana
Biggest News Aggregation in the World

Page 35 - Peter Marks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Marks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Marks Today - Breaking & Trending Today

Lisa Jarvis: Measles outbreak should be a vaccine wake-up call - Vimarsana News

Lisa Jarvis: Measles outbreak should be a vaccine wake-up call

A cluster of measles cases in the Northeast is putting a spotlight on how easily the highly contagious disease can spread — and how dangerous any further slip in childhood vaccination rates could be. Infants and toddlers not old enough to have been fully protected through vaccination are vulnerable to

Caissie Levy to Reprise Role in NEXT TO NORMAL West End Transfer - Vimarsana News

Caissie Levy to Reprise Role in NEXT TO NORMAL West End Transfer

The critically acclaimed cast of the smash hit Donmar Warehouse production of the Broadway musical Next to Normal – which sold every seat at every performance across its season at Donmar Warehouse, where the production made its long-awaited UK Premiere –are to return as the show prepares to transfer to London’s West End.

Banquet Records speak on future of Kingston Pryzm after news of owners entering administration - Vimarsana News

Banquet Records speak on future of Kingston Pryzm after news of owners entering administration

Banquet Records have shared a statement on the future of Kingston Pryzm after news of the company's owners entering administration.

Source: nme.com
Southampton: Clubbers waiting to hear if Switch will close - Vimarsana News

Southampton: Clubbers waiting to hear if Switch will close

One of Southampton's top nightspots is facing an uncertain future after its owners announced it was planning to call in administrators.

$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs - Vimarsana News

$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs

In a much-anticipated move, the Federal Drug Administration (FDA) has approved two new gene therapies for sickle cell disease